Brief: Eton Pharmaceuticals Enters Into Amendment To Asset Purchase
15/06/2023 22:12
June 15 (Reuters) - Eton Pharmaceuticals Inc ETON.O :
* ETON PHARMACEUTICALS INC- ON JUNE 15, ENTERED INTO
AMENDMENT TO
ASSET PURCHASE DEAL DATED DECEMBER 31, 2020 BY, BETWEEN CO AND
AZURITY
* ETON PHARMACEUTICALS INC- WILL SELL BACK TO AZURITY
ROYALTY
INTERESTS IT RECEIVED UNDER ORIGINAL AGREEMENT FOR TOTAL
CONSIDERATION OF $5.5 MILLION
Further company coverage: ETON.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Eton Pharmaceuticals
See all newsBrief: Eton Pharmaceuticals Under Agreement, Co Pays Aquestive Upfront License Fee Of $10 Million - SEC Filing
Aquestive rises on US licensing deal for seizure drug with Eton Pharma
U.S. STOCKS ON THE MOVE-Sun Communities, Cisco Systems, Paysafe
U.S. STOCKS ON THE MOVE-Fox, Sun Communities, Reddit, drone firms
U.S. STOCKS ON THE MOVE-Boost Run, Nektar Therapeutics, Swarmer